A novel γ-secretase assay based on detection of the putative C-terminal fragment-γ of amyloid β protein precursor

Inga Pinnix, Usha Musunuru, Han W Tun, Arati Sridharan, Todd Golde, Christopher Eckman, Chewki Ziani-Cherif, Luisa Onstead, Kumar Sambamurti

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

Alzheimer's disease is characterized by the deposits of the 4-kDa amyloid β peptide (Aβ). The Aβ protein precursor (APP) is cleaved by β-secretase to generate a C-terminal fragment, CTFβ, which in turn is cleaved by γ-secretase to generate Aβ. Alternative cleavage of the APP by α-secretase at Aβ16/17 generates the C-terminal fragment, CTFα. In addition to Aβ, endoproteolytic cleavage of CTFα and CTFβ by γ-secretase should yield a C-terminal fragment of 57-59 residues (CTFγ). However, CTFγ has not yet been reported in either brain or cell lysates, presumably due to its instability in vivo. We detected the in vitro generation of Aβ as well as an ∼6-kDa fragment from guinea pig brain membranes. We have provided biochemical and pharmacological evidence that this 6-kDa fragment is the elusive CTFγ, and we describe an in vitro assay for γ-secretase activity. The fragment migrates with a synthetic peptide corresponding to the 57-residue CTFγ fragment. Three compounds previously identified as γ-secretase inhibitors, pepstatin-A, MG132, and a substrate-based difluoroketone (t-butoxycarbonyl-Val-Ile-(S)-4-amino-3-oxo-2,2-difluoropentanoyl-Val-Ile-OMe ), reduced the yield of CTFγ, providing additional evidence that the fragment arises from γ-secretase cleavage. Consistent with reports that presenilins are the elusive γ-secretases, subcellular fractionation studies showed that presenilin-1, CTFα, and CTFβ are enriched in the CTFγ-generating fractions. The in vitro γ-secretase assay described here will be useful for the detailed characterization of the enzyme and to screen for γ-secretase inhibitors.

Original languageEnglish (US)
Pages (from-to)481-487
Number of pages7
JournalJournal of Biological Chemistry
Volume276
Issue number1
DOIs
StatePublished - Jan 5 2001

Fingerprint

Amyloid Precursor Protein Secretases
Amyloid beta-Protein Precursor
Assays
Protein Precursors
Brain
Presenilins
Presenilin-1
Fractionation
Amyloid
Alzheimer Disease
Guinea Pigs
Deposits
Pharmacology
Membranes

ASJC Scopus subject areas

  • Biochemistry

Cite this

A novel γ-secretase assay based on detection of the putative C-terminal fragment-γ of amyloid β protein precursor. / Pinnix, Inga; Musunuru, Usha; Tun, Han W; Sridharan, Arati; Golde, Todd; Eckman, Christopher; Ziani-Cherif, Chewki; Onstead, Luisa; Sambamurti, Kumar.

In: Journal of Biological Chemistry, Vol. 276, No. 1, 05.01.2001, p. 481-487.

Research output: Contribution to journalArticle

Pinnix, I, Musunuru, U, Tun, HW, Sridharan, A, Golde, T, Eckman, C, Ziani-Cherif, C, Onstead, L & Sambamurti, K 2001, 'A novel γ-secretase assay based on detection of the putative C-terminal fragment-γ of amyloid β protein precursor', Journal of Biological Chemistry, vol. 276, no. 1, pp. 481-487. https://doi.org/10.1074/jbc.M005968200
Pinnix, Inga ; Musunuru, Usha ; Tun, Han W ; Sridharan, Arati ; Golde, Todd ; Eckman, Christopher ; Ziani-Cherif, Chewki ; Onstead, Luisa ; Sambamurti, Kumar. / A novel γ-secretase assay based on detection of the putative C-terminal fragment-γ of amyloid β protein precursor. In: Journal of Biological Chemistry. 2001 ; Vol. 276, No. 1. pp. 481-487.
@article{765352cef68f4728b3d921966122c34d,
title = "A novel γ-secretase assay based on detection of the putative C-terminal fragment-γ of amyloid β protein precursor",
abstract = "Alzheimer's disease is characterized by the deposits of the 4-kDa amyloid β peptide (Aβ). The Aβ protein precursor (APP) is cleaved by β-secretase to generate a C-terminal fragment, CTFβ, which in turn is cleaved by γ-secretase to generate Aβ. Alternative cleavage of the APP by α-secretase at Aβ16/17 generates the C-terminal fragment, CTFα. In addition to Aβ, endoproteolytic cleavage of CTFα and CTFβ by γ-secretase should yield a C-terminal fragment of 57-59 residues (CTFγ). However, CTFγ has not yet been reported in either brain or cell lysates, presumably due to its instability in vivo. We detected the in vitro generation of Aβ as well as an ∼6-kDa fragment from guinea pig brain membranes. We have provided biochemical and pharmacological evidence that this 6-kDa fragment is the elusive CTFγ, and we describe an in vitro assay for γ-secretase activity. The fragment migrates with a synthetic peptide corresponding to the 57-residue CTFγ fragment. Three compounds previously identified as γ-secretase inhibitors, pepstatin-A, MG132, and a substrate-based difluoroketone (t-butoxycarbonyl-Val-Ile-(S)-4-amino-3-oxo-2,2-difluoropentanoyl-Val-Ile-OMe ), reduced the yield of CTFγ, providing additional evidence that the fragment arises from γ-secretase cleavage. Consistent with reports that presenilins are the elusive γ-secretases, subcellular fractionation studies showed that presenilin-1, CTFα, and CTFβ are enriched in the CTFγ-generating fractions. The in vitro γ-secretase assay described here will be useful for the detailed characterization of the enzyme and to screen for γ-secretase inhibitors.",
author = "Inga Pinnix and Usha Musunuru and Tun, {Han W} and Arati Sridharan and Todd Golde and Christopher Eckman and Chewki Ziani-Cherif and Luisa Onstead and Kumar Sambamurti",
year = "2001",
month = "1",
day = "5",
doi = "10.1074/jbc.M005968200",
language = "English (US)",
volume = "276",
pages = "481--487",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "1",

}

TY - JOUR

T1 - A novel γ-secretase assay based on detection of the putative C-terminal fragment-γ of amyloid β protein precursor

AU - Pinnix, Inga

AU - Musunuru, Usha

AU - Tun, Han W

AU - Sridharan, Arati

AU - Golde, Todd

AU - Eckman, Christopher

AU - Ziani-Cherif, Chewki

AU - Onstead, Luisa

AU - Sambamurti, Kumar

PY - 2001/1/5

Y1 - 2001/1/5

N2 - Alzheimer's disease is characterized by the deposits of the 4-kDa amyloid β peptide (Aβ). The Aβ protein precursor (APP) is cleaved by β-secretase to generate a C-terminal fragment, CTFβ, which in turn is cleaved by γ-secretase to generate Aβ. Alternative cleavage of the APP by α-secretase at Aβ16/17 generates the C-terminal fragment, CTFα. In addition to Aβ, endoproteolytic cleavage of CTFα and CTFβ by γ-secretase should yield a C-terminal fragment of 57-59 residues (CTFγ). However, CTFγ has not yet been reported in either brain or cell lysates, presumably due to its instability in vivo. We detected the in vitro generation of Aβ as well as an ∼6-kDa fragment from guinea pig brain membranes. We have provided biochemical and pharmacological evidence that this 6-kDa fragment is the elusive CTFγ, and we describe an in vitro assay for γ-secretase activity. The fragment migrates with a synthetic peptide corresponding to the 57-residue CTFγ fragment. Three compounds previously identified as γ-secretase inhibitors, pepstatin-A, MG132, and a substrate-based difluoroketone (t-butoxycarbonyl-Val-Ile-(S)-4-amino-3-oxo-2,2-difluoropentanoyl-Val-Ile-OMe ), reduced the yield of CTFγ, providing additional evidence that the fragment arises from γ-secretase cleavage. Consistent with reports that presenilins are the elusive γ-secretases, subcellular fractionation studies showed that presenilin-1, CTFα, and CTFβ are enriched in the CTFγ-generating fractions. The in vitro γ-secretase assay described here will be useful for the detailed characterization of the enzyme and to screen for γ-secretase inhibitors.

AB - Alzheimer's disease is characterized by the deposits of the 4-kDa amyloid β peptide (Aβ). The Aβ protein precursor (APP) is cleaved by β-secretase to generate a C-terminal fragment, CTFβ, which in turn is cleaved by γ-secretase to generate Aβ. Alternative cleavage of the APP by α-secretase at Aβ16/17 generates the C-terminal fragment, CTFα. In addition to Aβ, endoproteolytic cleavage of CTFα and CTFβ by γ-secretase should yield a C-terminal fragment of 57-59 residues (CTFγ). However, CTFγ has not yet been reported in either brain or cell lysates, presumably due to its instability in vivo. We detected the in vitro generation of Aβ as well as an ∼6-kDa fragment from guinea pig brain membranes. We have provided biochemical and pharmacological evidence that this 6-kDa fragment is the elusive CTFγ, and we describe an in vitro assay for γ-secretase activity. The fragment migrates with a synthetic peptide corresponding to the 57-residue CTFγ fragment. Three compounds previously identified as γ-secretase inhibitors, pepstatin-A, MG132, and a substrate-based difluoroketone (t-butoxycarbonyl-Val-Ile-(S)-4-amino-3-oxo-2,2-difluoropentanoyl-Val-Ile-OMe ), reduced the yield of CTFγ, providing additional evidence that the fragment arises from γ-secretase cleavage. Consistent with reports that presenilins are the elusive γ-secretases, subcellular fractionation studies showed that presenilin-1, CTFα, and CTFβ are enriched in the CTFγ-generating fractions. The in vitro γ-secretase assay described here will be useful for the detailed characterization of the enzyme and to screen for γ-secretase inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=0035808416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035808416&partnerID=8YFLogxK

U2 - 10.1074/jbc.M005968200

DO - 10.1074/jbc.M005968200

M3 - Article

C2 - 11035007

AN - SCOPUS:0035808416

VL - 276

SP - 481

EP - 487

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 1

ER -